| 1 | depending | 3,790 |
| 2 | focusing | 2,372 |
| 3 | relying | 252 |
| 4 | concentrating | 165 |
| 5 | focussing | 136 |
| 6 | basing | 107 |
| 7 | capitalizing | 19 |
| 8 | commenting | 15 |
| 9 | burton | 4 |
| 10 | capitalising | 4 |
| 11 | j·kg·l·m | 4 |
| 12 | primer/bonding | 4 |
| 13 | assay-impact | 3 |
| 14 | phoretic | 3 |
| 15 | rs11057830 | 3 |
| 16 | 5/min | 2 |
| 17 | adamts6 | 2 |
| 18 | drks00003497 | 2 |
| 19 | fes-et | 2 |
| 20 | piggy-backing | 2 |
| 21 | progesteron* | 2 |
| 22 | re-warm-ups | 2 |
| 23 | st7-b | 2 |
| 24 | unrefreshed | 2 |
| 25 | 'emphasis | 1 |
| 26 | 'explanation | 1 |
| 27 | 'reflection | 1 |
| 28 | 'treatise | 1 |
| 29 | +0.084 | 1 |
| 30 | 1.4.1987-31.7.1988 | 1 |
| 31 | 11,500/mm3 | 1 |
| 32 | 15-and | 1 |
| 33 | 2.08-27.04 | 1 |
| 34 | 2.09-157.93 | 1 |
| 35 | 22-dien-3β-ol | 1 |
| 36 | 221.13s | 1 |
| 37 | 3.27-49.79 | 1 |
| 38 | 3/auc0-24 | 1 |
| 39 | 34.4±8.9°c | 1 |
| 40 | 5-sec | 1 |
| 41 | 51.5mg/g | 1 |
| 42 | 59±2mm | 1 |
| 43 | 6.8-4.4 | 1 |
| 44 | 610,500 | 1 |
| 45 | 70,000/g | 1 |
| 46 | 8arginine-caco₃ | 1 |
| 47 | 9,883 | 1 |
| 48 | 9.4/10 | 1 |
| 49 | anxiolitikami | 1 |
| 50 | aprx-sequences | 1 |
| 51 | aronow | 1 |
| 52 | biospec | 1 |
| 53 | bsed | 1 |
| 54 | c.834_835insg | 1 |
| 55 | carabello | 1 |
| 56 | characteristics/specifications | 1 |
| 57 | ci,2.44-15.20 | 1 |
| 58 | colr | 1 |
| 59 | culture/rt-pcr | 1 |
| 60 | drainage-free | 1 |
| 61 | dura-tion | 1 |
| 62 | estimate=-.74 | 1 |
| 63 | frowned | 1 |
| 64 | gender-interaction | 1 |
| 65 | gloverin-1 | 1 |
| 66 | grogginess | 1 |
| 67 | head-coordinates | 1 |
| 68 | in/effects | 1 |
| 69 | inhibion | 1 |
| 70 | isrctn78556552 | 1 |
| 71 | km₂ | 1 |
| 72 | largus | 1 |
| 73 | manifestated | 1 |
| 74 | mbs≥65 | 1 |
| 75 | mediastinal-ratio | 1 |
| 76 | myalgia-free | 1 |
| 77 | navpa | 1 |
| 78 | pemi/k | 1 |
| 79 | postpyelonephritis | 1 |
| 80 | premagnified | 1 |
| 81 | rs2048417 | 1 |
| 82 | rs7834588 | 1 |
| 83 | rs878953 | 1 |
| 84 | sb126763 | 1 |
| 85 | spiro-ergometry | 1 |
| 86 | strung | 1 |
| 87 | switching/adding | 1 |
| 88 | tf-antigen | 1 |
| 89 | three-needles | 1 |
| 90 | timeand | 1 |
| 91 | tnf-alpha-antagonists | 1 |
| 92 | todate | 1 |
| 93 | tonicising | 1 |
| 94 | volume/frequency | 1 |
| 95 | wheezing/whistling | 1 |
| 96 | widely.if | 1 |
| 97 | δsuv13 | 1 |
| 1 | 'emphasis | 1 |
| 2 | 'explanation | 1 |
| 3 | 'reflection | 1 |
| 4 | 'treatise | 1 |
| 5 | +0.084 | 1 |
| 6 | 1.4.1987-31.7.1988 | 1 |
| 7 | 11,500/mm3 | 1 |
| 8 | 15-and | 1 |
| 9 | 2.08-27.04 | 1 |
| 10 | 2.09-157.93 | 1 |
| 11 | 22-dien-3β-ol | 1 |
| 12 | 221.13s | 1 |
| 13 | 3.27-49.79 | 1 |
| 14 | 3/auc0-24 | 1 |
| 15 | 34.4±8.9°c | 1 |
| 16 | 5-sec | 1 |
| 17 | 5/min | 2 |
| 18 | 51.5mg/g | 1 |
| 19 | 59±2mm | 1 |
| 20 | 6.8-4.4 | 1 |
| 21 | 610,500 | 1 |
| 22 | 70,000/g | 1 |
| 23 | 8arginine-caco₃ | 1 |
| 24 | 9,883 | 1 |
| 25 | 9.4/10 | 1 |
| 26 | adamts6 | 2 |
| 27 | anxiolitikami | 1 |
| 28 | aprx-sequences | 1 |
| 29 | aronow | 1 |
| 30 | assay-impact | 3 |
| 31 | basing | 107 |
| 32 | biospec | 1 |
| 33 | bsed | 1 |
| 34 | burton | 4 |
| 35 | c.834_835insg | 1 |
| 36 | capitalising | 4 |
| 37 | capitalizing | 19 |
| 38 | carabello | 1 |
| 39 | characteristics/specifications | 1 |
| 40 | ci,2.44-15.20 | 1 |
| 41 | colr | 1 |
| 42 | commenting | 15 |
| 43 | concentrating | 165 |
| 44 | culture/rt-pcr | 1 |
| 45 | depending | 3,790 |
| 46 | drainage-free | 1 |
| 47 | drks00003497 | 2 |
| 48 | dura-tion | 1 |
| 49 | estimate=-.74 | 1 |
| 50 | fes-et | 2 |
| 51 | focusing | 2,372 |
| 52 | focussing | 136 |
| 53 | frowned | 1 |
| 54 | gender-interaction | 1 |
| 55 | gloverin-1 | 1 |
| 56 | grogginess | 1 |
| 57 | head-coordinates | 1 |
| 58 | in/effects | 1 |
| 59 | inhibion | 1 |
| 60 | isrctn78556552 | 1 |
| 61 | j·kg·l·m | 4 |
| 62 | km₂ | 1 |
| 63 | largus | 1 |
| 64 | manifestated | 1 |
| 65 | mbs≥65 | 1 |
| 66 | mediastinal-ratio | 1 |
| 67 | myalgia-free | 1 |
| 68 | navpa | 1 |
| 69 | pemi/k | 1 |
| 70 | phoretic | 3 |
| 71 | piggy-backing | 2 |
| 72 | postpyelonephritis | 1 |
| 73 | premagnified | 1 |
| 74 | primer/bonding | 4 |
| 75 | progesteron* | 2 |
| 76 | re-warm-ups | 2 |
| 77 | relying | 252 |
| 78 | rs11057830 | 3 |
| 79 | rs2048417 | 1 |
| 80 | rs7834588 | 1 |
| 81 | rs878953 | 1 |
| 82 | sb126763 | 1 |
| 83 | spiro-ergometry | 1 |
| 84 | st7-b | 2 |
| 85 | strung | 1 |
| 86 | switching/adding | 1 |
| 87 | tf-antigen | 1 |
| 88 | three-needles | 1 |
| 89 | timeand | 1 |
| 90 | tnf-alpha-antagonists | 1 |
| 91 | todate | 1 |
| 92 | tonicising | 1 |
| 93 | unrefreshed | 2 |
| 94 | volume/frequency | 1 |
| 95 | wheezing/whistling | 1 |
| 96 | widely.if | 1 |
| 97 | δsuv13 | 1 |
| 1 | progesteron* | 2 |
| 2 | 610,500 | 1 |
| 3 | 9.4/10 | 1 |
| 4 | ci,2.44-15.20 | 1 |
| 5 | rs11057830 | 3 |
| 6 | gloverin-1 | 1 |
| 7 | isrctn78556552 | 1 |
| 8 | δsuv13 | 1 |
| 9 | rs878953 | 1 |
| 10 | sb126763 | 1 |
| 11 | 9,883 | 1 |
| 12 | 2.09-157.93 | 1 |
| 13 | 11,500/mm3 | 1 |
| 14 | 6.8-4.4 | 1 |
| 15 | 2.08-27.04 | 1 |
| 16 | 3/auc0-24 | 1 |
| 17 | estimate=-.74 | 1 |
| 18 | +0.084 | 1 |
| 19 | mbs≥65 | 1 |
| 20 | adamts6 | 2 |
| 21 | rs2048417 | 1 |
| 22 | drks00003497 | 2 |
| 23 | rs7834588 | 1 |
| 24 | 1.4.1987-31.7.1988 | 1 |
| 25 | 3.27-49.79 | 1 |
| 26 | navpa | 1 |
| 27 | st7-b | 2 |
| 28 | biospec | 1 |
| 29 | 5-sec | 1 |
| 30 | phoretic | 3 |
| 31 | 34.4±8.9°c | 1 |
| 32 | unrefreshed | 2 |
| 33 | premagnified | 1 |
| 34 | frowned | 1 |
| 35 | bsed | 1 |
| 36 | manifestated | 1 |
| 37 | 15-and | 1 |
| 38 | timeand | 1 |
| 39 | myalgia-free | 1 |
| 40 | drainage-free | 1 |
| 41 | 'treatise | 1 |
| 42 | todate | 1 |
| 43 | widely.if | 1 |
| 44 | 70,000/g | 1 |
| 45 | 51.5mg/g | 1 |
| 46 | switching/adding | 1 |
| 47 | depending | 3,790 |
| 48 | primer/bonding | 4 |
| 49 | piggy-backing | 2 |
| 50 | wheezing/whistling | 1 |
| 51 | basing | 107 |
| 52 | tonicising | 1 |
| 53 | capitalising | 4 |
| 54 | focussing | 136 |
| 55 | focusing | 2,372 |
| 56 | concentrating | 165 |
| 57 | commenting | 15 |
| 58 | relying | 252 |
| 59 | capitalizing | 19 |
| 60 | strung | 1 |
| 61 | c.834_835insg | 1 |
| 62 | anxiolitikami | 1 |
| 63 | pemi/k | 1 |
| 64 | 22-dien-3β-ol | 1 |
| 65 | 59±2mm | 1 |
| 66 | j·kg·l·m | 4 |
| 67 | tf-antigen | 1 |
| 68 | 5/min | 2 |
| 69 | inhibion | 1 |
| 70 | dura-tion | 1 |
| 71 | 'explanation | 1 |
| 72 | gender-interaction | 1 |
| 73 | 'reflection | 1 |
| 74 | burton | 4 |
| 75 | mediastinal-ratio | 1 |
| 76 | carabello | 1 |
| 77 | culture/rt-pcr | 1 |
| 78 | colr | 1 |
| 79 | 221.13s | 1 |
| 80 | aprx-sequences | 1 |
| 81 | three-needles | 1 |
| 82 | head-coordinates | 1 |
| 83 | 'emphasis | 1 |
| 84 | postpyelonephritis | 1 |
| 85 | characteristics/specifications | 1 |
| 86 | re-warm-ups | 2 |
| 87 | grogginess | 1 |
| 88 | in/effects | 1 |
| 89 | tnf-alpha-antagonists | 1 |
| 90 | largus | 1 |
| 91 | assay-impact | 3 |
| 92 | fes-et | 2 |
| 93 | aronow | 1 |
| 94 | volume/frequency | 1 |
| 95 | spiro-ergometry | 1 |
| 96 | km₂ | 1 |
| 97 | 8arginine-caco₃ | 1 |